Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anticoagulation therapy and bone metabolism].

V Krislo1, P Dubac, M Sorf

  • 1II. interné a hematologicko-transfúzne oddelenie NsP, Nové Mesto.

Vnitrni Lekarstvi
|October 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[European cataract outcome study--evaluation of 3 years in European study].

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2009
Same author

[Hemophilic arthropathy as a multidisciplinary problem].

Vnitrni lekarstvi·2000
Same author

[The incidence of anemia in the Slovak population].

Vnitrni lekarstvi·1994
Same author

[Atrophy of the gastric mucosa and Helicobacter pylori].

Vnitrni lekarstvi·1993
Same author

[von Hippel-Lindau disease].

Bratislavske lekarske listy·1993
Same author

[Ambulatory therapy of internal hemorrhoids using infrared photocoagulation and elastic ligature].

Vnitrni lekarstvi·1993

Warfarin, a coumarin anticoagulant, did not significantly alter key bone metabolism markers like parathormone, calcium, phosphatemia, or alkaline phosphatase in patients undergoing prolonged treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Bone Metabolism

Context:

  • Anticoagulation therapy, particularly with coumarin derivatives and heparin, is increasingly utilized in clinical practice.
  • Prolonged anticoagulation necessitates a thorough understanding of its potential effects on bone health.
  • Warfarin is a widely prescribed oral anticoagulant with a significant patient population requiring long-term treatment.

Purpose:

  • To investigate the impact of Warfarin (coumarin) on specific biochemical indicators of bone metabolism.
  • To assess changes in parathormone, serum calcium, phosphatemia, and alkaline phosphatase isoenzyme levels during Warfarin therapy.

Summary:

  • This study examined 17 patients receiving Warfarin treatment.
  • No statistically significant alterations were observed in parathormone, serum calcium, phosphatemia, or alkaline phosphatase isoenzyme levels.

Related Experiment Videos

  • Bone metabolism indicators remained stable during the investigated period of coumarin anticoagulation.

    • Impact:

    • Provides evidence that Warfarin therapy may not adversely affect key bone metabolism markers in the short term.
    • Informs clinical decisions regarding the safety of prolonged anticoagulation with Warfarin concerning bone health.
    • Highlights the need for continued research into the long-term skeletal effects of anticoagulants.